(Q34128082)

English

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

Leishmania major

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

31 July 2017

9

object named as

Steven G Reed

1 reference

Europe PubMed Central

31 July 2017

1

object named as

Rhea N Coler

1 reference

Europe PubMed Central

31 July 2017

author name string

Yasir A W Skeiky

2

1 reference

Europe PubMed Central

31 July 2017

Karen Bernards

3

1 reference

Europe PubMed Central

31 July 2017

Kay Greeson

4

1 reference

Europe PubMed Central

31 July 2017

Charisa D Cornellison

6

1 reference

Europe PubMed Central

31 July 2017

Farrokh Modabber

7

1 reference

Europe PubMed Central

31 July 2017

Antonio Campos-Neto

8

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

31 July 2017

Infection and Immunity

1 reference

Europe PubMed Central

31 July 2017

70

1 reference

Europe PubMed Central

31 July 2017

8

1 reference

Europe PubMed Central

31 July 2017

4215-4225

1 reference

Europe PubMed Central

31 July 2017

Practical progress and new drugs for changing patterns of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Protective immune responses induced by vaccination with an expression genomic library of Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Vaccine for prophylaxis and immunotherapy, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

T-cell and cytokine responses in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Expression cloning of a protective Leishmania antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

The present and future of vaccination for cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Membrane glycoprotein M-2 protects against Leishmania amazonensis infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

Immunoprotective Leishmania major synthetic T cell epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

5 July 2018

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

28 October 2018

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

28 October 2018

LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

28 October 2018

IL-12 as an adjuvant for cell-mediated immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

28 October 2018

Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128156

28 October 2018

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of protective immunity against Leishmania major in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of leishmanization in the control of cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major

1 reference

https://pubmed.ncbi.nlm.nih.gov/12117930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/IAI.70.8.4215-4225.2002

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34128082&oldid=1970224032"